UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

No change in insulin sensitivity in renal transplant recipients converted from standard to once-daily prolonged release tacrolimus

Nephrology, dialysis, transplantation, 2011-11, Vol.26 (11), p.3767-3772

2011

Volltextzugriff (PDF)

Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology

Therapeutic drug monitoring, 2021-04, Vol.43 (2), p.150

2021

Volltextzugriff (PDF)

Longitudinal Study of Tacrolimus in Lymphocytes During the First Year After Kidney Transplantation

Therapeutic drug monitoring, 2018-10, Vol.40 (5), p.558

2018

Volltextzugriff (PDF)

Comparing the Effects of the mTOR Inhibitors Azithromycin and Rapamycin on In Vitro Expanded Regulatory T Cells

Cell transplantation, 2019-12, Vol.28 (12), p.1603-1613

2019

Volltextzugriff (PDF)

Increased systemic exposure of once‐daily tacrolimus in renal transplant recipients on marine omega‐3 fatty acid supplementation

Transplant international, 2021-07, Vol.34 (7), p.1322-1324

2021

Volltextzugriff (PDF)

Pharmacodynamic assessment of mycophenolic acid in resting and activated target cell population during the first year after renal transplantation

British journal of clinical pharmacology, 2020-06, Vol.86 (6), p.1100-1112

2020

Volltextzugriff (PDF)

Differential Gemcitabine Sensitivity in Primary Human Pancreatic Cancer Cells and Paired Stellate Cells Is Driven by Heterogenous Drug Uptake and Processing

Cancers, 2020-12, Vol.12 (12), p.3628

2020

Volltextzugriff (PDF)

Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects

BMC cardiovascular disorders, 2021-12, Vol.21 (1), p.596-596, Article 596

2021

Volltextzugriff (PDF)

The atorvastatin metabolite pattern in muscle tissue and blood plasma is associated with statin muscle side effects in patients with coronary heart disease; An exploratory case-control study

Atherosclerosis plus, 2024-03, Vol.55, p.31-38

2024

Volltextzugriff (PDF)

Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy

Therapeutic drug monitoring, 2006-10, Vol.28 (5), p.608

2006

Volltextzugriff (PDF)

Treatment with Tacrolimus and Sirolimus Reveals No Additional Adverse Effects on Human Islets In Vitro Compared to Each Drug Alone but They Are Reduced by Adding Glucocorticoids

Journal of Diabetes Research, 2016-01, Vol.2016, p.4196460-9

2016

Volltextzugriff (PDF)

Pharmacodynamics of mycophenolic acid in CD4+ cells: a single-dose study of IMPDH and purine nucleotide responses in healthy individuals

Therapeutic drug monitoring, 2008-12, Vol.30 (6), p.647

2008

Volltextzugriff (PDF)

Drug target molecules to guide immunosuppression

Clinical biochemistry, 2016-03, Vol.49 (4-5), p.411-418

2016

Volltextzugriff (PDF)

A novel direct method to determine adherence to atorvastatin therapy in patients with coronary heart disease

British journal of clinical pharmacology, 2019-12, Vol.85 (12), p.2878-2885

2019

Volltextzugriff (PDF)

Fast and reliable quantification of busulfan in blood plasma using two-channel liquid chromatography tandem mass spectrometry: Validation of assay performance in the presence of drug formulation excipients

Journal of pharmaceutical and biomedical analysis, 2021-09, Vol.203, p.114216-114216, Article 114216

2021

Volltextzugriff (PDF)

Therapeutic Drug Monitoring of Intravenous Busulfan and Analytical Challenges due to the Drug Formulation Excipient PEG 400: Letter to the Editor

Therapeutic drug monitoring, 2024-06, Vol.46 (3), p.416

2024

Volltextzugriff (PDF)

Clinical performance of volumetric finger‐prick sampling for the monitoring of tacrolimus, creatinine and haemoglobin in kidney transplant recipients

British journal of clinical pharmacology, 2023-12, Vol.89 (12), p.3690-3701

2023

Volltextzugriff (PDF)

Tacrolimus Measured in Capillary Volumetric Microsamples in Pediatric Patients-A Cross-Validation Study

Therapeutic drug monitoring, 2021-06, Vol.43 (3), p.371

2021

Volltextzugriff (PDF)

Tailored clinical management after blinded statin challenge improved the lipid control in coronary patients with self‐perceived muscle side effects

Journal of internal medicine, 2022-06, Vol.291 (6), p.891-893

2022

Volltextzugriff (PDF)

Nytt verktøy for tolkning av farmakogenetiske analyser

Tidsskrift for den Norske Lægeforening, 2023-09

2023

Volltextzugriff (PDF)

In vitro assessments predict that CYP3A4 contributes to a greater extent than CYP3A5 to prednisolone clearance

Basic & clinical pharmacology & toxicology, 2021-12, Vol.129 (6), p.427-436

2021

Volltextzugriff (PDF)

Monitoring Simvastatin Adherence in Patients With Coronary Heart Disease: A Proof-of-Concept Study Based on Pharmacokinetic Measurements in Blood Plasma

Therapeutic drug monitoring, 2022-08, Vol.44 (4), p.558

2022

Volltextzugriff (PDF)

Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed

Transplantation, 2015-03, Vol.99 (3), p.528

2015

Volltextzugriff (PDF)

Atorvastatin Metabolite Pattern in Skeletal Muscle and Blood from Patients with Coronary Heart Disease and Statin‐Associated Muscle Symptoms

Clinical pharmacology and therapeutics, 2023-04, Vol.113 (4), p.887-895

2023

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(48)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(37)
Science & Technology
(37)
Humans
(30)
Pharmacology & Pharmacy
(18)
Female
(15)
Male
(15)
Middle Aged
(13)
Toxicology
(13)
Medical Laboratory Technology
(12)
Transplantation
(12)
Aged
(11)
Adult
(10)
Immunosuppressive Agents - Pharmacokinetics
(9)
Tacrolimus
(9)
Coronary Heart Disease
(8)
Therapeutic Drug Monitoring
(8)
Transplants & Implants
(8)
Cross-Over Studies
(7)
Drug Monitoring
(7)
Immunosuppressive Agents - Administration & Dosage
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report

No change in insulin sensitivity in renal transplant recipients converted from standard to once-daily prolonged release tacrolimus

Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology

Longitudinal Study of Tacrolimus in Lymphocytes During the First Year After Kidney Transplantation

Comparing the Effects of the mTOR Inhibitors Azithromycin and Rapamycin on In Vitro Expanded Regulatory T Cells

Increased systemic exposure of once‐daily tacrolimus in renal transplant recipients on marine omega‐3 fatty acid supplementation

Pharmacodynamic assessment of mycophenolic acid in resting and activated target cell population during the first year after renal transplantation

Differential Gemcitabine Sensitivity in Primary Human Pancreatic Cancer Cells and Paired Stellate Cells Is Driven by Heterogenous Drug Uptake and Processing

Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects

The atorvastatin metabolite pattern in muscle tissue and blood plasma is associated with statin muscle side effects in patients with coronary heart disease; An exploratory case-control study

Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy

Treatment with Tacrolimus and Sirolimus Reveals No Additional Adverse Effects on Human Islets In Vitro Compared to Each Drug Alone but They Are Reduced by Adding Glucocorticoids

Pharmacodynamics of mycophenolic acid in CD4+ cells: a single-dose study of IMPDH and purine nucleotide responses in healthy individuals

Drug target molecules to guide immunosuppression

A novel direct method to determine adherence to atorvastatin therapy in patients with coronary heart disease

Fast and reliable quantification of busulfan in blood plasma using two-channel liquid chromatography tandem mass spectrometry: Validation of assay performance in the presence of drug formulation excipients

Therapeutic Drug Monitoring of Intravenous Busulfan and Analytical Challenges due to the Drug Formulation Excipient PEG 400: Letter to the Editor

Clinical performance of volumetric finger‐prick sampling for the monitoring of tacrolimus, creatinine and haemoglobin in kidney transplant recipients

Tacrolimus Measured in Capillary Volumetric Microsamples in Pediatric Patients-A Cross-Validation Study

Tailored clinical management after blinded statin challenge improved the lipid control in coronary patients with self‐perceived muscle side effects

Nytt verktøy for tolkning av farmakogenetiske analyser

In vitro assessments predict that CYP3A4 contributes to a greater extent than CYP3A5 to prednisolone clearance

Monitoring Simvastatin Adherence in Patients With Coronary Heart Disease: A Proof-of-Concept Study Based on Pharmacokinetic Measurements in Blood Plasma

Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed

Atorvastatin Metabolite Pattern in Skeletal Muscle and Blood from Patients with Coronary Heart Disease and Statin‐Associated Muscle Symptoms

Suchergebnisse filtern